ANOS1 was predominantly enriched in pathways related to ECM receptor interaction, focal adhesion, hematological cell lineage, chemotherapy signaling, pathways in cancer, and the TGF-β signaling pathway in GC. The gene discussed is ANOS1; the disease is cancer.